MedTrace Logo

PillCam Colon 2 Capsule Endoscopy (PCCE) After Incomplete Colonoscopy

NCT01480635 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 74

Last updated 2011-11-29

No results posted yet for this study

Summary

Purpose of study:

To evaluate the efficacy of PillCam Colon2 in subjects with an incomplete standard colonoscopy

Study design: 4 centers, prospective, cohort study Number of subjects: 74 subjects

Subject population: Patients that are indicated for colonoscopy, who are suspected or known to suffer from colonic diseases and had an incomplete standard colonoscopy

Control group: None Procedure Duration: Approximately 10-12 hours Duration of Follow up: One week follow up Duration of study: 12 months

Primary objectives: Evaluation of the efficacy of PillCam Colon2 to visualize the colon segment not reached by an incomplete standard colonoscopy Evaluation of distribution of excretion of capsules over time

Conditions

  • Colonoscopy

Sponsors & Collaborators

  • Medtronic - MITG

    collaborator INDUSTRY

  • Bethesda Krankenhaus

    lead OTHER

Principal Investigators

  • Martin Keuchel, Dr. · Bethesda Krankenhaus Bergedorf, Hamburg, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2012-07-31
Completion
2012-10-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01480635 on ClinicalTrials.gov